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Abstract
Rationale Social functioning is modulated by the endogenous opioid system. In opioid use disorder, social functioning appears
disrupted, but little research has delineated the nature of these deficits and their relationship to acute opioid use.
Objectives The current study aimed to assess both emotional and cognitive empathy, along with subjective and physiological
responses to social exclusion in opioid users who were either acutely intoxicated or non-intoxicated from using opioids.
Methods Individuals on an opioid substitution medication (OSM) were divided into ‘intoxicated users’ (had taken their OSM the
same day as testing, n = 20) and ‘non-intoxicated users’ (had taken their OSM > 12 h ago, n = 20) and compared with opioid-
naïve controls (n = 24). Empathywas assessed using themultifaceted empathy test and self-report questionnaire. Participants also
underwent a period of social exclusion (Cyberball Game) and completed measures of mood and physiological responses (salivary
cortisol and heart rate).
Results Non-intoxicated users had significantly lower emotional empathy (the ability to experience others’ emotions), as well as
greater anger after social exclusion when compared with the intoxicated users and controls. Anger did not change with social
exclusion in the intoxicated user group and cortisol levels were lower overall.
Conclusions Reduced ability to spontaneously share the emotions of others was reported in non-intoxicated users, particularly
regarding positive emotions. There was some support for the idea of hyperalgesia to social pain, but this was restricted to an
enhanced anger response in non-intoxicated users. Equivalent rates of empathy between the intoxicated users and controls could
indicate some remediating effects of acute opioids.
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Introduction
The misuse of opioids is a growing global concern, with ap-
proximately 34 million users worldwide and recent reports of
a dramatic increase in overdose rates (United Nations of
Office on Drugs and Crime 2018). As well as high rates of
mortali ty, opioid misuse has other health-related
consequences, such as increased rates of HIV, hepatitis C
and neonatal abstinence syndrome (National Institute on
Drug Abuse 2018). Understanding the factors that initiate
and maintain opioid use disorder is thus imperative from a
public health perspective. Much work has focused on the bi-
ological and behavioural mechanisms of opioid addiction;
however, research into the role of psychosocial factors is com-
paratively sparse (Heilig et al. 2016). It is well understood that
social factors including social deprivation and interpersonal
trauma can predict and maintain addiction (Gerra et al.
2014; Heffernan et al. 2000; Kendler et al. 2014; Lake et al.
2015; MacGregor and Thickett 2011; Naqavi et al. 2011).
Opioids may be used in part to compensate for difficulties in
emotion regulation (Moustafa et al. 2018; Wolff et al. 2016).
Additionally, high rates of social marginalisation, ostracism
and discrimination towards addicted individuals (Barry et al.
2014) may perpetuate deficits in social functioning and could
contribute to the maintenance of opioid use.
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Neurobiologically, the endogenous opioid system plays a
role in social functioning (see Machin and Dunbar 2011, for a
review) and is involved in empathy (Rutgen et al. 2015),
which has a uniquely social purpose (Panksepp and
Panksepp 2013; Pearce et al. 2017). Empathy is crucial for
interpersonal relationships and bonding: impairments in the
ability to empathise are observed in disorders such as autism
spectrum disorder (Baron-Cohen and Wheelwright 2004) and
schizophrenia (Green et al. 2015), and are related to difficul-
ties in social functioning (Baron-Cohen and Wheelwright
2004). Impaired empathy in people with substance use disor-
ders has also been reported (Ferrari et al. 2014). Two pivotal
aspects of empathy are ‘emotional empathy’, referring to the
ability to vicariously feel the emotional state of others, and
‘cognitive empathy’, which refers to the ability to identify and
understand the emotional state of others (sometimes referred
to as ‘theory of mind’) (Baron-Cohen and Wheelwright 2004;
Blair 2005). Impairments in emotional empathy have been
observed in drug users generally (Ferrari et al. 2014), alcohol
users (Maurage et al. 2011) and stimulant users (Kroll et al.
2018a, 2018b; Preller et al. 2014). Two studies with chronic
opioid users have similarly reported impairments in emotional
empathy using a subjective questionnaire among methadone-
and diacetylmorphine-maintained individuals (Stange et al.
2017; Tomei et al. 2017) but a further study failed to replicate
these findings (Kroll et al. 2018a). The ability to empathise
can be affected by situational factors including psychosocial
stress, affective state, and socioeconomic status (Kanske et al.
2017), where acute opioid intoxication state may also be im-
portant to understand impairments in empathy within the con-
text of wider social stress.
Opioid drugs may also affect social functioning by altering
responses to difficult social events. Acutely, exogenous opi-
oids have shown to alleviate the experience of both physical
and emotional pain (Bershad et al. 2016; Inturrisi 2002; Stein
et al. 2007). The latter is termed ‘emotional analgesia’ and is
thought to be a protective mechanism from emotional pain,
and is associated with reductions in subjective distress and
cortisol following social exclusion (Bass et al. 2014).
‘Social’ pain is used to refer to a specific form of emotional
pain, such as the painful feelings following an unpleasant
social event like bullying, social rejection or exclusion
(Eisenberger 2015). Both social and physical pain have over-
lapping neural mechanisms (however see Iannetti et al. 2013,
for a review of the differences). Similar to physical pain, the
brain responds to social pain (exclusion) by releasing endor-
phins to buffer against the unpleasant emotional experience
(Hsu et al. 2013).
Pain perception is altered following chronic use of opioid
drugs. Studies have consistently reported a heightened sensi-
tivity to physical pain in chronic opioid users (Compton et al.
2001; Higgins et al. 2018; Mao 2002; Marion Lee et al. 2011;
Pud et al. 2006). Increased opioid tolerance via the
downregulation of endogenous opioid receptors has been sug-
gested to underpin opioid-induced hyperalgesia (Higgins et al.
2018; Mao 2002). As physical and social pain share some
similar neural mechanisms (Eisenberger 2015; Hsu et al.
2013), it is plausible to suggest that alterations in opioid re-
ceptor function could similarly cause a heightened sensitivity
to social, as well as physical, pain. To our knowledge, only
one study has investigated the link between chronic opioid use
and the experience of social pain in non-intoxicated opioid
users, and found a heightened cortisol response to social ex-
clusion (Kroll et al. 2019). We do not yet know how being
acutely intoxicated affects response to social exclusion and
empathy in opioid users, which may be a powerful factor in
maintaining problematic substance use.
Therefore, the current study aimed to investigate alterations
in social functioning by measuring empathy and responses to
social exclusion among individuals with histories of chronic
opioid use.We aimed to examine both the acute and long-term
effects of opioids in people prescribed an opioid substitution
medication (OSM), by testing people intoxicated with OSM at
the time of testing, and people who had not taken their med-
ication for at least 12 hours. Based on previous research show-
ing deficits in empathy in opioid users, we hypothesised that
both of the opioid user groups would show impairments in
empathy; however, given evidence that opioid intoxication is
associated with impaired emotional empathy (Stange et al.
2017; Tomei et al. 2017), we predicted that emotional empa-
thy would be most impaired in the intoxicated group.
Secondly, we hypothesised that the intoxicated user group
would have a dampened response to social exclusion—
based on the analgesic effects of opioids and the assertion that
physical and social pain are related. We further predicted that
the non-intoxicated user group would be more subjectively
affected by social exclusion given the hyperalgesia to physical
pain seen in non-intoxicated opioid users.
Method
Design and participants
Sixty-four participants (39 males; 24 females; 1 non-binary)
aged 22–67 (M = 42.69, SD = 11.54) were recruited into the
study. Forty were opioid users currently stabilised on OSM
(methadone or buprenorphine), and all had histories of illicit
heroin use. Of these, 20 individuals took their opioid prescrip-
tion in the morning of the study (intoxicated group), and 20
individuals had taken their prescription > 12 h ago (non-in-
toxicated group). Group membership was validated with tests
of salivary opioid levels. The remaining 24 individuals were
opioid-naïve controls with no history of opioid use. Groups
were matched in age, gender and verbal IQ. Participants were
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recruited via word of mouth and advertisements in drug ser-
vices and employment/training agencies.
The study was a mixed design. Inclusion criteria for the
opioid groups were a prolonged history of opioid use and
currently taking daily OSM. General inclusion criteria were
being a minimum of 18 years old and a fluent English speaker.
Exclusion criteria were neurological conditions, history of se-
vere mental health issues, diagnosis of a physical illness that
directly influences cortisol activity (i.e. Cushing or Addison
disease), taking oral steroid medication and pregnancy.
Individuals were excluded from the control group if they
had any history of opioid use. Participants were asked to ab-
stain from alcohol and drugs 24 h prior to their study session
and abstain from smoking or eating for 45 min prior to their
session. The study was reviewed by the institutional ethics
committee and was conducted in accordance with the
Declaration of Helsinki, all participants gave written,
witnessed, informed consent.
Measures
Multifaceted empathy test (MET, see Fig 1) (Dziobek et al.
2008)This computerised task indexes cognitive and emotional
empathy. Forty photographs of people with emotionally
charged expressions are given in eight blocks consisting of
ten pictures each. In half of these blocks, participants are asked
to identify the correct emotion of the subject in each scene
(cognitive empathy). In the other half, participants were asked
to rate how much they empathise with the individual in each
scene (emotional empathy). Each image was presented until
the participant gave a response, and participants were asked to
respond as quickly as possible. The task lasted approximately
15 min. Responses for cognitive empathy were the total count
of correctly identified emotions, while responses for emotion-
al empathy were the mean empathy score.
The Cyberball Game (Williams et al. 2012) This is a
computerised ball-tossing game shown to simulate social ex-
clusion. Participants are told that they are playing real people
on a virtual network in a mental visualisation experiment, yet
unbeknown to them the other players are fictitious and were
set up to socially exclude them. In the present study, the
Cyberball Game contained four players and had two condi-
tions that simulated either social inclusion or exclusion. There
were two games: inclusion followed by exclusion, and each
game lasted between 2 and 4 min. Each condition had approx-
imately 60 ball throws between the four players. In the social
inclusion condition, participants were over-included and re-
ceived 20 ± 1 (~ 33.3%) of 60 ball throws. In the exclusion
game, participants received exactly 6 ± 1 (~ 10%) of 60 ball
throws.
Affective and physiological responses to social inclusion
and exclusion were recorded after each game with the Post-
ostracism Cyberball Questionnaire (Williams et al. 2002),
which assessed mood and basic psychological needs (see sup-
plementary material (SM1) for more details)
Physiological measures Seven saliva samples were collected
by passive drool method. Participants were required to pro-
vide approximately 2 ml of saliva, which was immediately
stored at − 80 °C until analysis using enzyme-linked immu-
nosorbent assay (ELISA) kits to assess cortisol levels, as well
as levels of methadone, buprenorphine and opiates (baseline
sample only). Heart rate was also assessed alongside each
saliva sample (see SM1 for details).
Questionnaires
Trait empathy was assessed using the Interpersonal Reactivity
Index (IRI; Davis 1980), which consists of four different sub-
scales: two characterise emotional empathy (empathic con-
cern; personal distress), and two characterise cognitive
How much do you empathise with this 0person? 
 1  2  3  4  5  6  7  8  9 
(not at all) (very much) 
What emotion is this person feeling? 
1. Amused 2. Content 3. Curious 4. Adoring 
Correct response: 2. Content
Fig. 1 Differential blocks
assessing cognitive and emotional
empathy in the MET. a For
cognitive empathy, participants
were required to pick one of four
emotion labels. b For emotional
empathy, participants were asked
to rate howmuch they empathised
(which they were instructed
means ‘feel what they are
feeling’) with the subject in the
photo using a 9-point Likert Scale
(1 = not at all; 9 = very much).
Image taken with permission
from the task creator (Dziobek
et al. 2008)
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empathy (perspective taking; fantasy scale). The Life Events
Checklist Version 5 (LEC-5;Weathers et al. 2013) was used to
assess trauma by measuring past exposure to any stressful or
traumatic life events, and how proximal these events were to
the participant (adapted to include age). Loneliness was mea-
sured using the UCLA Loneliness Scale (Russell 1996) which
assesses feelings of social isolation and loneliness. Craving
was assessed using three single items of drug liking, wanting
and motivation to obtain opioid drugs (Pool et al. 2016).
Verbal IQ was assessed using the Spot-the-Word Test
(Baddeley et al. 1993). Mood at baseline was also assessed
using the Positive and Negative Affect Schedule (Watson et al.
1988). See SM1 for further details of each psychometric
measure.
Procedure
Participants arrived in the afternoon between the times of 1
and 1.30 pm to control for diurnal variation in cortisol, and
testing lasted for approximately 2 h. All procedures and ap-
proximate timings are depicted in Fig. 2.
Upon completion of all procedures, participants were fully
debriefed on the true nature of the study, and given an oppor-
tunity to ask any questions. Participants were remunerated for
their participation with a voucher.
Statistical analysis
Data were analysed using the Statistical Package for Social
Sciences (SPSS) version 23 and Mplus version 8.
Assumptions of normality were checked, extreme outliers
were winsorized (Wilcox 2005) and random missing values
were imputed by group mean substitution.
A series of one-way, between-subject ANOVAs were used
to assess the effect of group on both emotional and cognitive
empathy. For the Cyberball Games, subjective responses to
social exclusion were analysed using a series of 3 × 2 mixed
measures ANOVAs assessed the effects of group and inclu-
sion status on subjective measures (the PCQ and craving). For
the cortisol and heart rate, latent growth curve models
(LGCM) were used to understand the between-person differ-
ence in the trajectory of responses over time in respect to the
average trend (Muthén and Curran 1997; Willett and Sayer
1994) and encompass features of both structural equation
modelling and repeated measures ANOVA (Duncan et al.
2013) (described in SM2).
Any significant interactions were investigated further using
post hoc t tests, which were adjusted using the Holm-
Bonferroni correction. Differences between groups in demo-
graphic information was analysed using t tests, Chi-square
tests where data was categorical and the Kruskal-Wallis test
(groups > 3) or Mann-WhitneyU (groups < 2) test where data
was non-parametric. Pearson’s correlations were used to as-
sess statistical relationships, and Spearman’s correlations were
used when normality was violated.
Latent growth curve modelling (LGCM) To investigate if the
levels of opioid exposure (‘Group’) were associated with dif-
ferent physiological response trajectories throughout the tasks,
we applied LGCM using Mplus (Muthén and Muthén 2000)
(the growth model procedure is described in more detail in
SM2). Model fit was assessed using the comparative fit index
(CFI), the Tucker-Lewis index (TLI), the root mean squared
Fig. 2 Study procedures in
sequential order and accompanied
by approximate timings. There
were seven time points where
physiological measures (salivary
cortisol and blood pressure) were
collected, and are labelled
‘Physiol.’ in red
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error of approximation (RMSEA) and the standardised root
mean square residual (SRMR). Improvements in the model
were assessed using both the Bayesian information criterion
(aBIC) and Akaike information criterion (AIC). The robust
maximum likelihood estimation (MLR) was used for each
model.
Results
Demographics and drug use (Table 1)
Groups were matched in age, gender, ethnicity, alcohol use,
verbal IQ, baseline positive affect and familial history of sub-
stance abuse problems and mental health problems. There
were differences in the number of diagnosed mental health
problems, with increased incidence of mental health problems
in the non-intoxicated opioid users compared to controls (χ2 =
11.13, p = .004), but no other differences (Holm-Bonferroni
corrected). Although there was an overall group difference in
age individuals left education and baseline negative affect,
after correction for multiple comparisons, there were no group
differences.
There was a significant difference in the number of months
taking an OSM between the two opioid user groups, with a
greater number of months on OSM in the intoxicated (see
Table 1). There were significant group differences in sub-
stance use for opioids, tobacco, cannabis and cocaine users
comparing both the opioid groups to the controls (χ2 = 15.02,
p = .012; χ2 = 14.53, p = .012; χ2 = 7.44, p = .042; and χ2 =
9.79, p = .016, respectively); however, there were no signifi-
cant differences in illicit substance use between the two opioid
user groups (χ2 = 0.00, p > .999, χ2 = 1.29, p > .999; χ2 =
0.00, p > .999; and χ2 = 0.11, p > .999, respectively) (Holm-
Bonferroni corrected). Further details on drug use history can
be found in SM3.
Hypothesis 1: impairment in emotional empathy
The multifaceted empathy test (MET) For emotional empathy,
there was a significant difference in group (F(2,61) = 3.52, p =
.036, η2 = .10). Holm-Bonferroni t tests indicated the non-
intoxicated user group scored significantly lower than the con-
trols (t(42) = 2.64, p = .048, η2 = .14) (Fig. 3); however, there
were no differences between the non-intoxicated users and the
intoxicated users (t(38) = 1.91, p = .128, η2 = .09) or the
intoxicated users and controls (t(42) = 0.40, p = .688, η2 <
.01). Emotional empathy to either positive or negative affect
was also explored (all analyses were Holm-Bonferroni
corrected). For positive affect, there was an effect of group
(F(2,61) = 6.39, p = .024, η2 = .17), where the non-
intoxicated group rated significantly lower than controls
(t(42) = 4.03, p = .002, η2 = .28). There were no differences
between the intoxicated and non-intoxicated users (t(38) =
1.53, p = .512, η2 = .06) or intoxicated users and controls
(t(42) = 1.78, p = .415, η2 = .07) (Fig. 3). For negative affect,
there were no differences between groups (F(2,61) = 1.99, p =
.512, η2 = .06).
When assessing cognitive empathy, there were no signifi-
cant differences between the three groups (F(2,56) = 1.76, p =
.182, η2 = .04). Number of words known in the MET was
included as a covariate in this analysis due to being correlated
with cognitive empathy (r = .55, n = 60, p < .001). There were
no group differences in cognitive empathy for positive or neg-
ative affect (F(2,61) = 1.07, p = .696, η2 = .03, and F(2,61) =
1.03, p = .696, η2 = .03, respectively) (Holm-Bonferroni
corrected). For M and SDs for MET subscales, see SM4.
The Interpersonal Reactivity Index (IRI) For emotional empa-
thy subscales, there were no significant group differences in
‘empathic concern’ (F(2,61) = 0.14, p = .871, η2 = .01) or
‘personal distress’ (F(2,61) = 0.05, p = .950, η2 < .01). For
cognitive empathy subscales, there were no significant group
differences in ‘perspective taking’ (F(2,61) = 0.95, p = .394,
η2 = .03) or ‘fantasy’ (F(2,61) = 1.62, p = .206, η2 = .05) (for
M and SDs, see SM4).
Hypothesis 2: chronic opioid users show dampened
responses to social pain
The Cyberball Task There were significant main effects of
inclusion status which reflected decreases in mood, self-es-
teem, control, meaningful existence and sense of belonging
following exclusion, as well as increases in hurt feelings.
However, there were no significant effects of group, or inter-
action between inclusion status and group (Table 2).
For Anger, there was a significant interaction between in-
clusion status and group (F(2,61) = 5.42, p = .007, η2 = .10).
Holm-Bonferroni corrected pairwise comparisons indicated
that there was a significant difference in anger between the
non-intoxicated user group with the intoxicated group (p <
.001) and controls (p < .001); however, there were no differ-
ences between the intoxicated group with controls (p = .561)
(Fig. 4). There was also a main effect of inclusion status
(F(1,61) = 14.11, p < .001, η2 = .13), alongside a main effect
of group (F(2,61) = 12.12, p < .001, η2 = .24). There were no
effects of group or inclusion status on opioid craving (SM5).
Physiological responses
Salivary cortisol The LGCM with continuous latent variables
of intercept for cortisol at minute 0 (baseline) and a quadratic
slope as outcome between minutes 0 and 119 including
dummy-coded group as the covariate revealed a good fit
χ2(22) = 34.54, p = .043, CFI = .94; TLI = .93; SRMR =
.07; RMSEA = .09, 90%CI [0.02,0.15]; AIC = − 1064.34;
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aBIC = − 1027.66. Being intoxicated was negatively related
with the intercept at 0 minutes (b = − 0.07, SE = 0.03, p =
.016), suggesting they had lower cortisol levels at baseline
compared to the controls, but there were no effects for the
non-intoxicated group (b = − 0.01, SE = 0.04, p = .759) who
showed similar cortisol levels as the controls (Fig. 5a). In
addition, there were significant effects of the intoxicated
group when the intercept was set at minutes 46 (post-
Table 1 Demographic information and drug use between groups (means and standard deviations)
Intoxicated (n = 20) Non-intoxicated (n = 20) Controls (n = 24) Test statistic P value
Age 44.45 (11.51) 40.40 (10.04) 43.13 (12.83) F = 0.64 .533
Gender (male, female, other) 12, 8, 0 14, 6, 0 13, 10, 1 χ2 = 2.56 .663
Ethnicity (Caucasian, Hispanic, mixed) 20, 0, 0 18, 1, 1 21, 0, 3 χ2 = 5.20 .267
Age left education 16.25 (1.55) 15.32 (3.79) 17.65 (3.25) F = 3.26 .045*
Verbal IQ 47.35 (10.82) 44.89 (8.91) 48.83 (5.76) F = 1.09 .342
Mental health problems (n = yes) 11 16 8 χ2 = 11.12 .004**
Diagnosis (n) Depression 10 14 6
Anxiety 5 2 1
Other 0 2 1
Physical health problems (n = yes) 6 4 3 χ2 = 2.04 .360
Antidepressants (n = yes) 7 10 5 χ2 = 4.72 .095
Oral contraceptives (n = yes) 1 1 0 χ2 = 1.71 .426
Familial mental health problems (n = yes) 4 6 9 χ2 = 1.61 .447
Familial substance use disorder (n = yes) 7 4 6 χ2 = 1.04 .595
Baseline positive affect 28.33 (7.50) 29.72 (8.17) 29.92 (7.13) F = 0.25 .779
Baseline negative affect 14.16 (5.56) 15.45 (6.20) 11.71 (2.94) F = 3.23 .046*
Opioid substitution medications (OSM)
Medication, n (methadone, buprenorphine, other) 16, 1, 3 12, 6, 2 χ2 = 4.34 .114
Dose (standardised to oral morphineb, mg) 28.78 (17.24) 36.43 (19.32) F = 1.75 .194
Months taken OSM 60.00 (173.25)a 12.00 (31.00)a U = 106.0 .011*
Hours since taken OSM 3.92 (2.01) 23.41 (7.65) F = 114.19 < .001***
Current regular drug use (n)
Illicit opioids 9 9 0 χ2 = 15.03 .001
Alcohol 11 12 13 χ2 = 0.17 .919
Tobacco 14 17 7 χ2 = 15.46 < .001***
Cannabis 8 8 2 χ2 = 7.44 .024*
Benzodiazepines 3 3 0 χ2 = 3.97 .137
Cocaine 7 6 0 χ2 = 9.94 .007**
Salivary opioid screens n = 20 n = 20
Methadone, n = positive, % due to opioid prescription 16, 100% 13, 83.3%
Buprenorphine, n = positive 0 1, 100%
Opiates, n = positive 6, 33.3% 1, 0%
Urine drug screens n = 20 n = 15 n = 24
Methadone, n = positive 14 10 0
Opiates, n = positive 9 8 0
Cannabis/THC, n = positive 6 5 3
Cocaine, n = positive 5 5 2
Amphetamine, n = positive 1 1 2
Benzodiazepines, n = positive 3 7 0
MDMA, n = positive 0 1 0
Note: a Non-parametric data: median and IQR are reported
b The equivalent doses are an approximation and calculated from the following sources (Foley 1985; Royal College of Anaesthetists 2018)
Current regular use of MDMA, amphetamines, and hallucinogens were excluded from the table due to minimal numbers
*p < .05, **p < .01, ***p < .001
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inclusion), 60 (post-exclusion), 85 (recovery period) and 101
(recovery period) (see SM6 for the data) indicating that in-
toxicated users had lower cortisol responses throughout
social exclusion and recovery in comparison to the non-
intoxicated and controls. Neither being intoxicated (b =
0.01, SE = 0.01, p = .326) nor being non-intoxicated (b
< 0.01, SE = 0.01, p = .690) was associated with the
slope, suggesting that the trajectory of cortisol over time
was not associated to acute opioid state.
Heart rate A piecewise LGCM with continuous latent vari-
ables of intercept, with one linear slope from 46 to 68 min (the
Cyberball paradigm) and the second linear slope from 85 to
119min (post-exclusion recovery period) in heart rate change,
including group and interpersonal trauma as a covariate re-
vealed the best and an overall acceptable fit χ2(21) = 36.73,
p = .018, CFI = .95; TLI = .92; SRMR = .04; RMSEA = .12,
90%CI [0.05, 0.18]; AIC = 2008.64; aBIC = 2056.81. Being
intoxicated had a significant negative effect on the intercept at
46 min (b = − 4.77, SE = 2.17, p = .028) (Fig. 5b), suggesting
lower heart rate at baseline. In addition, there were significant
effects of the intoxicated group when the intercept was set at
minutes 60 and 101 and minutes 68 and 119 (see SM6) indi-
cating that intoxicated users had less change in heart rate
throughout social exclusion and recovery in comparison to
the non-intoxicated and controls. There were no significant
slope effects but the intoxicated user group had a near-
significant effect on the linear slope between 46 and 68 min
(b = 1.04, SE = 0.55, p = .057), and a similar trend was
observed in the non-intoxicated user group (b = 1.26, SE =
0.71, p = .075) suggesting a gentler downward slope com-
pared with the control condition. There was also a trend to
suggest the effect of the intoxicated user group on the linear
slope between 85 and 119 min (b = − 1.46, SE = 0.84, p =
.081), suggesting smaller change during the recovery period
compared with the controls. Rates of interpersonal trauma did
not exert any significant effects on the intercept or slopes
although adding it improved overall model fit.
Exploratory analyses
Emotional empathy was not correlated with the total months
taking an OSM (rs = − .372, n = 20, p = .424) or hours since
the OSM was taken (r = − .159, n = 15, p > .999) within the
non-intoxicated group, nor was it correlated with rates of men-
tal health problems over the sample (r = .03 n = 63, p < .999).
There was a medium effect size for the association between
emotional empathy and OSM dose within the non-intoxicated
user group; however, it failed to reach significance (r = − .49,
n = 20, p = .203).
Negative affect at baseline was not significantly related to
emotional empathy for positive emotions (r = − 0.04, n = 63, p
= .773) or change in anger from inclusion to exclusion (r = −
0.07, n = 63, p = .606).
Discussion
The current study aimed to assess empathy and responses to
social exclusion among individuals with opioid use disorder.
We found lower emotional empathy (i.e., the ability to vicar-
iously experience the emotional state of others) among non-
intoxicated opioid users compared with opioid-naïve controls,
particularly for positive emotions. Non-intoxicated opioid
users also expressed significantly greater anger after being
socially excluded compared to the intoxicated user group
and controls. On the other hand, intoxicated opioid users
showed lower salivary cortisol and heart rate across the testing
Fig. 3 Emotional empathy on the
MET between the three groups.
There were significantly lower
emotional empathy overall in the
non-intoxicated opioid user group
compared with the controls (*p <
.05). When broken down into
positive and negative affect, there
were significant lower levels of
emotional empathy for positive
emotions in the non-intoxicated
user group compared with con-
trols (**p < .01); however, there
were no differences between the
intoxicated users and controls, or
any group differences in negative
affect
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session; however, they did not differ in the level at which
cortisol and heart rate particularly increased or decreased in
response to social exclusion.
The finding of lower emotional empathy in the non-
intoxicated users partially replicates previous research sug-
gesting impaired empathy among drug users (Ferrari et al.
2014; Kroll et al. 2018a, 2018b; Maurage et al. 2011; Preller
et al. 2014) and opioid users specifically (Kroll et al. 2018a;
Stange et al. 2017; Tomei et al. 2017), but crucially highlight-
ed that acutely intoxicated opioid users show intact emotional
empathy compared to controls. This was contrary to our initial
prediction that empathy would be lowest within the intoxicat-
ed user group. Previous work in healthy participants has con-
nected higher levels of endogenous opioids with decreased
empathy for pain, possibly due to a decreased sensitivity in
the ability to feel pain in oneself (Rutgen et al. 2015); there-
fore, it has been suggested that the use of analgesic drugs like
opioids could also reduce empathy. Our results suggest that
this is not the case in this group of chronic opioid users and, in
fact, the on-board opioids appear to repair their empathy to the
level of controls, whereas non-intoxicated users showed
impairments—specifically for positive emotions. There was
a medium to large effect size for the correlation between opi-
oid substitution medication (OSM) dose and emotional empa-
thy, potentially indicating a dose-dependent reduction in emo-
tional empathy within the non-intoxicated group that was not
driven by outliers. However, this should be interpreted with
caution, as this relationship was using a small sample size and
was non-significant after adjusting the α-criterion for multiple
comparisons. Further work should investigate whether there is
Table 2 Statistical outcomes for the Cyberball Subscales and opioid craving
Inclusion status Intoxicated Non-
intoxicated
Control F-statistic p value η2
ΔMood Inclusion 2.49 (1.04) 2.27 (1.35) 2.62 (0.83) Group 1.95 .151 .03
Exclusion 1.65 (1.92) 0.36 (2.03) 0.95 (1.74) Inclusion status 39.00 < .001*** .18
Group*inclusion status 1.79 .176 .02
Self-esteem Inclusion 3.02 (1.33) 2.80 (1.23) 3.44 (0.95) Group 1.63 .205 .09
Exclusion 2.41 (1.31) 1.87 (0.85) 2.25 (0.89) Inclusion status 47.28 < .001*** .39
Group*inclusion status 1.68 .196 .03
Sense of belonginga Inclusion 1.35 (0.48) 1.32 (0.71) 1.14 (0.28) Group 0.77 .466 .02
Exclusion 2.45 (1.43) 2.92 (1.48) 2.53 (1.13) Inclusion status 69.46 < .001*** .52
Group*inclusion status 0.74 .480 .01
Meaningful existencea Inclusion 0.09 (1.78) 0.11 (0.16) 0.03 (0.08) Group 2.23 .116 .03
Exclusion 0.34 (0.22) 0.35 (0.26) 0.26 (0.21) Inclusion status 52.13 < .001*** .28
Group*inclusion status < .01 .996 < .01
Controla Inclusion 0.30 (0.20) 0.31 (0.20) 0.38 (0.17) Group 1.06 .352 .02
Exclusion 0.18 (0.22) 0.09 (0.16) 0.16 (0.20) Inclusion status 68.12 < .001*** .20
Group*inclusion status 1.97 .148 .01
Anger Inclusion 1.15 (0.67) 1.40 (0.88) 1.04 (0.20) Group 12.12 < .001*** .24
Exclusion 1.15 (0.37) 2.50 (1.32) 1.46 (0.78) Inclusion status 14.22 < .001*** .13
Group*inclusion status 5.42 .007 .10
Hurt feelingsa Inclusion 0.02 (0.07) 0.02 (0.11) 0.02 (0.08) Group 0.20 .822 < .01
Exclusion 0.19 (0.27) 0.23 (0.27) 0.19 (0.25) Inclusion status 32.25 < .001*** .19
Group*inclusion status 0.09 .910 < .01
% of perceived ball throws Inclusion 32.93 (10.75) 38.62 (23.12) 41.47 (19.81) Group 0.91 .409 .01
Exclusion 15.27 (9.87) 11.14 (6.24) 16.03 (11.18) Inclusion status 62.61 < .001*** .39
Group*inclusion status 0.97 .386 .01
ΔMoodb (baseline to exclusion) Baseline 14.35 (8.91) 13.83 (11.05) 18.21 (9.52) Group 0.68 .508 .02
Exclusion 7.22 (14.06) 6.44 (12.09) 8.58 (12.41) Inclusion status 32.06 < .001*** .11
Group*inclusion status 0.43 .652 < .01
Note: ΔMood was calculated by subtracting negative affect scores from overall positive affect scores. The adjectives used to compute positive mood in
the PCQ were good, happy, friendly, relaxed, whilst negative mood were bad, sad, unfriendly and tense
a Log transformation was applied. Mean values are adjusted for the log transformation
bΔMood (baseline to exclusion) is a manipulation check that Cyberball exclusion condition caused reductions in mood from baseline (using responses on
the PANAS rather than mood assessed by the PCQ)
Psychopharmacology
a dose dependent relationship between opioid use and
empathy.
The specific impairment in empathy for positive emotions
was demonstrated previously in a similar study with opioid
users (Kroll et al. 2018a). This suggests a possible negative
bias where relating to positive emotions is more difficult for
opioid users not currently experiencing the acute effects of
opioids. Prior research has suggested that abstinent opioid
addicts are biased when attending to negative emotions, where
they show enhanced detection of negative expressions during
a visual search paradigm (Zhou et al. 2012). This bias is po-
tentially due to greater exposure to negative expressions and
reactions from society in everyday life, as well as impaired
emotion processing that could predate addiction (Zhou et al.
2012). Additional to this, distress intolerance—the inability to
endure difficult emotional states—is associated with greater
attentional bias towards negative emotions and decreased at-
tention toward positive emotions (Macatee et al. 2018).
Opioid users on an OSM show greater distress intolerance
(KathrynMcHugh and Otto 2012), where opioids may height-
en the threshold to cope with difficult emotional states. The
empathy deficit for positive emotions in the non-intoxicated
users may therefore be due to reduced exposure to positive
emotions in everyday life and reduced attention towards them.
Opioid intoxication may serve to remediate emotion difficul-
ties by increasing distress tolerance and enhancing their ability
to relate to positive emotions.
The study also reported a novel finding of increased rates
of anger following social exclusion in the non-intoxicated
opioid users, compared to the intoxicated user group and con-
trols. Past research has linked anger expression with endoge-
nous opioid functioning, suggesting that increased anger ex-
pression may be related to an impaired endogenous opioid
response to stress (Bruehl et al. 2007). Preclinical evidence
supports this assumption, finding that opioid blockade using
naltrexone has shown to increase rates of anger and pain
(Bruehl et al. 2008; Burns et al. 2009). As the non-
intoxicated user group in the current study may have a damp-
ened endogenous opioid response, this could possibly account
for the large increase in anger after being socially excluded.
The intoxicated user group may experience no change in an-
ger due to the acute effects of opioids buffering from this
unpleasant emotional state. Higher rates of hostility and anger
are related to poor emotion regulation in drug users
(Handelsman et al. 2000; Shabanloo et al. 2018). This finding
of greater anger, together with impaired empathy, potentially
suggests an overall impairment in both understanding and
expressing one’s own emotions in individuals who have
chronically used opioids but are not acutely under the influ-
ence of them. It could suggest that opioids are used to alleviate
difficult emotional states such as anger, and heighten users’
ability to tolerate social exclusion.
Cortisol and heart rate change were lower in the intoxicated
user group, which is to be expected given cardiac depression
following opioids (Vargish et al. 1987) and evidence that opi-
oids can reduce cortisol responses to psychosocial stress
(Bershad et al. 2015). Heart rate did not recover (reduce) over
the duration of the experiment for the non-intoxicated user
group; prior work has indicated the role of the endogenous
opioid system in the recovery of the cardiovascular response
to stress by reducing heart rate and cortisol (Morris et al.
1990). Heart rate has been linked with emotional and cogni-
tive functions, where lower heart rate variability is related with
poorer emotion regulation, higher alcohol craving
(Ingjaldsson et al. 2003), and lower empathy (Lischke et al.
2018). Moreover, the groups did not differ in physiological
responses to social exclusion and over the recovery period as
we expected. A psychosocial stressor such as the Trier Social
Stress Test (Kirschbaum et al. 1993) may produce more robust
changes in cortisol and heartrate.
The current findings on empathy broadly concur with im-
pairments observed in a previous study of opioid users by
Kroll and colleagues (2018a) who also implemented the
Multifaceted Empathy Test (MET); however they reported
impairments in cognitive empathy (i.e. the ability to under-
stand and identify the emotional states of others) among
non-medically prescribed opioid users. The discrepancy be-
tween the two studies could be due to various differences
between our samples: the sample tested by Kroll et al. exclud-
ed those with history of heroin abuse, and consequently may
have experienced much lower levels of deprivation, poly-drug
use and social adversity than our sample. One similarity be-
tween the two studies is specific impairment to positive emo-
tions, which could suggest an overall negativity bias across
the samples irrespective of socioeconomic or drug use
background.
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Fig. 4 Anger following the inclusion and exclusion games between the
three groups. Both the non-intoxicated opioid user group and the controls
significantly increase in anger from inclusion to exclusion, whilst the
intoxicated opioid user group remain the same. There was also a signif-
icant main effect of inclusion status, and a significant main effect of group
(*p < .05)
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The study had limitations. Firstly, the intoxicated group had
been prescribed OSM for more months than the non-
intoxicated group; however, the months on OSM were not
correlated with empathy, and the impairment in empathy was
within the non-intoxicated group which suggests that this does
not account for the key findings of the study. Secondly, the
study did not measure symptoms of opioid withdrawal; how-
ever, this could have been linked with increased distress and
anger following rejection in the non-intoxicated group. In ad-
dition, high rates of polysubstance and antidepressant use were
reported in the opioid user groups, which could have biased the
results. Nonetheless, the two opioid groups are well matched in
drug use history which indicates a specific effect of opioid
intoxication on emotional empathy and post-exclusion anger.
The three groups were well matched in other variables, includ-
ing loneliness and history of childhood adversity.
In summary, the current study provides both novel findings
and supporting evidence for altered social functioning among
opioid users. Blunted subjective anger in response to stress
and lower cortisol and heart rate was observed in intoxicated
users, which partially supports the notion that opioids could
cause hyperalgesia to social pain. Impaired emotional empa-
thy and increased rates of anger among opioid users who are
not currently intoxicated with opioids may be due to an atten-
tional bias toward negative expressions and poorer ability to
tolerate difficult emotions, which is repaired by the use of
opioids. With this knowledge, potential treatments for opioid
use disorder should focus on heightening one’s ability to tol-
erate difficult social situations in a wider attempt to improve
social skills, alongside emotion regulation training specifical-
ly aimed at reducing anger.
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